Abstract
Although prevalence estimates are imprecise, growing numbers of women in the United States are living longer with metastatic breast cancer, attributable at least in part to the availability of effective targeted therapies. Women living with metastatic disease are understudied, however, and substantial heterogeneity exists in both the clinical characteristics of metastatic tumors and the physical and psychological experience of patients living with the disease. Survivorship issues are complex for patients who are living with metastatic disease over extended periods of time, from years to decades. Newly diagnosed patients with stage IV disease are confronting cancer for the first time, while others have metastatic disease as a result of breast cancer recurrence. Many patients are able to live for years on stable medical regimens, and yet others live with a moving target of aggressive disease with arduous treatments and uneven response. The psychological common denominator is the experience of profound life threat and the accompanying uncertainty, for both the affected woman and her loved ones. Maintaining life balance in the face of metastatic disease, as well as managing pain, fatigue, and other physical and psychological symptoms are major challenges. Increasingly, the clinical approach to metastatic disease reflects the consensus that palliative and supportive care are essential from the point of diagnosis. To remedy the paucity of systematic research on women living with metastatic breast cancer for extended periods, we offer directions for research to understand the experience of metastatic breast cancer and to provide evidence-based inter-professional care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aebi S, Gelber S, Anderson SJ, Láng I, Robidoux A, MartÃn M, Nortier JWR, Paterson AHG, Rimawi MF, Cañada JMB, Thürlimann B, Murray E, Mamounas EP, Geyer CE Jr, Price KN, Coates AS, Gelber RD, Rastogi P, Wolmark N, Wapnir IL (2014) Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol 15:156–163
Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, Leplege A, Lu A, Tulsky DS, Raat H, Ravens-Sieberer U, Revicki D, Terwee CB, Valderas JM, Cella D, Forrest CB (2013) The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health Qual Life Outcomes 11:210
Andersen BL, Shapiro CL, Farrar WB, Crespin T, Wells-Digregorio S (2005) Psychological responses to cancer recurrence. Cancer 104:1540–1547
Baselga J, Campone M, Piccart M, Burris HA III, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN (2012) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med 366:520–529
Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330:702
Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, Francis P, Gligorov J, Kyriakides S, Lin N, Pagani O, Senkus E, Thomssen C, Aapro M, Bergh J, Di LA, El SN, Ganz PA, Gelmon K, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Leadbeater M, Mayer M, Rodger A, Rugo H, Sacchini V, Sledge G, Van’t Veer L, Viale G, Krop I, Winer E (2012) 1st international consensus guidelines for advanced breast cancer (ABC 1). Breast 21:242–252
Cleary J, Ddungu H, Distelhorst SR, Ripamonti C, Rodin GM, Bushnaq MA, Clegg-Lamptey JN, Connor SR, Diwani MB, Eniu A, Harford JB, Kumar S, Rajagopal MR, Thompson B, Gralow JR, Anderson BO (2013) Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A breast health global initiative 2013 consensus statement. Breast 22:616–627
de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC (2012) Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer 118:6005–6011
Desantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62
Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R (2013) Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 31:782–793
Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355–1363
Howell D, Keller-Olaman S, Oliver TK, Hack TF, Broadfield L, Biggs K, Chung J, Gravelle D, Green E, Hamel M, Harth T, Johnston P, McLeod D, Swinton N, Syme A, Olson K (2013) A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol 20:e233–e246
Institute of Medicine (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. The National Academies Press, Washington, DC
Johnson RH, Chien FL, Bleyer A (2013) Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA 309:800–805
Low CA, Beran T, Stanton AL. (2007) Adaptation in the Face of Advanced Cancer. In Feuerstein M (ed) Handbook of Cancer Survivorship. pp 211–228, Springer
Miovic M, Block S (2007) Psychiatric disorders in advanced cancer. Cancer 110:1665–1676
Moreno PI, Stanton AL (2013) Personal growth during the experience of advanced cancer: a systematic review. Cancer J 19:421–430
Mustafa M, Carson-Stevens A, Gillespie D, Edwards AG (2013) Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev 6:CD004253
Oh S, Heflin L, Meyerowitz B, Desmond K, Rowland J, Ganz P (2004) Quality of life of breast cancer survivors after a recurrence: a follow-up study. Breast Cancer Res Treat 87:45–57
Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, Akechi T, Uchitomi Y (2000) Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat 61:131–137
Peppercorn JM, Smith TJ, Helft PR, Debono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH, Schnipper LE (2011) American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 29:755–760
Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von KJ, Taphoorn MJ, Weis J, Bottomley A (2011) Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst 103:1851–1858
Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, Peppercorn JM, Somerfield M, Stovall E, Von Roenn JH (2012) American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887
Stanton AL, Thompson EH, Crespi CM, Link JS, Waisman JR (2013) Project connect online: randomized trial of an internet-based program to chronicle the cancer experience and facilitate communication. J Clin Oncol 31:3411–3417
Thornton LM, Levin AO, Dorfman CS, Godiwala N, Heitzmann C, Andersen BL (2014) Emotions and social relationships for breast and gynecologic patients: a qualitative study of coping with recurrence. Psychooncology 23:382–389
Von Roenn JH (2013) Optimal cancer care: concurrent oncology and palliative care. J Natl Compr Canc Netw 11(Suppl 1):S1–S2
Yang HC, Brothers BM, Andersen BL (2008a) Stress and quality of life in breast cancer recurrence: moderation or mediation of coping? Ann Behav Med 35:188–197
Yang HC, Thornton LM, Shapiro CL, Andersen BL (2008b) Surviving recurrence: psychological and quality-of-life recovery. Cancer 112:1178–1187
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Breast Cancer Research Foundation
About this chapter
Cite this chapter
Ganz, P.A., Stanton, A.L. (2015). Living with Metastatic Breast Cancer. In: Ganz, P. (eds) Improving Outcomes for Breast Cancer Survivors. Advances in Experimental Medicine and Biology(), vol 862. Springer, Cham. https://doi.org/10.1007/978-3-319-16366-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-16366-6_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16365-9
Online ISBN: 978-3-319-16366-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)